In order to facilitate the determination of whether or not SCAND3 and Myo1g methylation could be good potential markers for early HCC detection, we analyzed the two gene methylation statuses in early-stage HCC patients. This evidence concerns the gene MYO1G and hepatocellular carcinoma.